These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33603844)

  • 1. Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma.
    Li GZ; Shen D; Li GH; Wei M; Zheng LJ; Liu ZL; Sun RQ; Zhou SJ; Zhang ZL; Gao YC
    Exp Ther Med; 2021 Mar; 21(3):236. PubMed ID: 33603844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of serum semaphorin 3B levels in preeclampsia.
    Wang H; Jiang L; Gao B; Dong M
    Clin Chim Acta; 2016 Apr; 455():60-3. PubMed ID: 26828533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal semaphorin 3B improves depression-like behaviours in mice by upregulating synaptic plasticity and inhibiting neuronal apoptosis.
    Du Y; Shi Y; Wang X; Song H; Wang X; Hao Y; Zhao Y; Guo X; Shi M; Gong M; Song L; Wang S; Gao Y; Shi H
    J Neurochem; 2022 Oct; 163(2):133-148. PubMed ID: 35892177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Kidney Int; 2006 May; 69(9):1564-9. PubMed ID: 16541019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
    Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
    Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
    Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
    Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of Semaphorin 5A in patients with rheumatoid arthritis and its effect on osteoclastogenesis].
    Du Y; Wang JW; Zhou MJ; Wu XY; Xue J; Wu HX
    Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):661-666. PubMed ID: 30180451
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated semaphorin 5A in patients with Hashimoto's thyroiditis: a case-control study.
    Liu Y; Wang S; Guo Q; Li Y; Qin J; Zhao N; Li Y; Shan Z; Teng W
    Endocr Connect; 2017 Nov; 6(8):659-666. PubMed ID: 28912336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis.
    Dhanabal M; Wu F; Alvarez E; McQueeney KD; Jeffers M; MacDougall J; Boldog FL; Hackett C; Shenoy S; Khramtsov N; Weiner J; Lichenstein HS; LaRochelle WJ
    Cancer Biol Ther; 2005 Jun; 4(6):659-68. PubMed ID: 15917651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum 14-3-3 beta in patients with hepatocellular carcinoma.
    Lin H; Jiao X; Yu B; Du J; Xu H; Dong A; Wan C
    Cancer Biomark; 2017 Aug; 20(2):143-150. PubMed ID: 28869445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma.
    Chen G; Wu H; Zhang L; Wei S
    Oncol Lett; 2020 Nov; 20(5):197. PubMed ID: 32963603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
    Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
    Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection.
    Hu ZQ; Zhou SL; Zhou ZJ; Luo CB; Chen EB; Zhan H; Wang PC; Dai Z; Zhou J; Fan J; Huang XW
    Oncotarget; 2016 Aug; 7(32):51733-51746. PubMed ID: 27351132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D.
    Liu Y; Zhou H; Ma L; Hou Y; Pan J; Sun C; Yang Y; Zhang J
    Tumour Biol; 2016 Jun; 37(6):8239-48. PubMed ID: 26718213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
    Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
    Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin 3A in Ankylosing Spondylitis.
    Liao HT; Lin YF; Chou CT; Tsai CY
    J Microbiol Immunol Infect; 2019 Feb; 52(1):151-157. PubMed ID: 28736223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.